Erythromycin Ethylsuccinate Market

Erythromycin Ethylsuccinate is the ethylsuccinate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin ethylsuccinate diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin ethylsuccinate may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
Treatment of acute and chronic vaginal infections eg, vaginitis and vulvo-vaginitis, mixed infections and unspecific infections due to Gardnerella vaginalis, fungal infections caused by Candida albicans, trichomonal infections, and for pre- and postoperative disinfection of the vagina.
Erythromycin Ethylsuccinate Market contains market size and forecasts of Erythromycin Ethylsuccinate in global, including the following market information:
Global Erythromycin Ethylsuccinate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Erythromycin Ethylsuccinate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Erythromycin Ethylsuccinate companies in 2021 (%)
The global Erythromycin Ethylsuccinate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.1g Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erythromycin Ethylsuccinate include Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences and Bide Pharmatech Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Erythromycin Ethylsuccinate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythromycin Ethylsuccinate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erythromycin Ethylsuccinate Market Segment Percentages, by Type, 2021 (%)
0.1g
0.25g
Global Erythromycin Ethylsuccinate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erythromycin Ethylsuccinate Market Segment Percentages, by Application, 2021 (%)
Anti-Bacterial Agents
Enzyme Inhibitors
Protein Synthesis Inhibitors
Gastrointestinal Agents
Global Erythromycin Ethylsuccinate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erythromycin Ethylsuccinate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythromycin Ethylsuccinate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Erythromycin Ethylsuccinate revenues share in global market, 2021 (%)
Key companies Erythromycin Ethylsuccinate sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Erythromycin Ethylsuccinate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.